2-Amino-3-[3-hydroxy-5-(2-methyl-2H-tetrazol-5-yl)-isoxazol-4-yl]-propionic acid

ID: ALA94859

PubChem CID: 3481675

Max Phase: Preclinical

Molecular Formula: C8H10N6O4

Molecular Weight: 254.21

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1nnc(-c2onc(O)c2CC(N)C(=O)O)n1

Standard InChI:  InChI=1S/C8H10N6O4/c1-14-11-6(10-13-14)5-3(7(15)12-18-5)2-4(9)8(16)17/h4H,2,9H2,1H3,(H,12,15)(H,16,17)

Standard InChI Key:  YXLQKZHKWIKJKC-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 18 19  0  0  0  0  0  0  0  0999 V2000
    3.9917   -6.3292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5792   -5.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8042   -4.9542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1167   -7.1542    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.1750   -6.2042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7917   -6.9375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.2667   -6.2042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3792   -7.5250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.9167   -5.6917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6292   -4.9167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3875   -4.2375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1500   -3.5167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5625   -4.2292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5667   -2.8042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.0375   -4.1917    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9750   -4.8167    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3167   -3.5125    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2417   -8.3417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  2  0
  4  1  2  0
  5  1  1  0
  6  5  2  0
  7  2  1  0
  8  4  1  0
  9  7  1  0
 10  3  1  0
 11  3  1  0
 12 13  1  0
 13 11  1  0
 14 12  2  0
 15 10  1  0
 16 13  1  0
 17 12  1  0
 18  8  1  0
  8  6  1  0
 10  9  2  0
M  END

Associated Targets(Human)

GRIA4 Tclin Glutamate receptor ionotropic AMPA (265 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GRIK1 Tclin Glutamate receptor ionotropic kainate (68 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GRIN1 Tclin Glutamate [NMDA] receptor (933 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Gria2 Glutamate receptor ionotropic, AMPA (2103 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Grik1 Glutamate receptor ionotropic, kainate (722 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Grin1 Glutamate NMDA receptor (6467 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Grik3 Glutamate receptor ionotropic kainate 3 (207 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Gria1 Glutamate receptor ionotropic, AMPA 1 (398 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Gria2 Glutamate receptor ionotropic, AMPA 2 (249 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Gria3 Glutamate receptor ionotropic, AMPA 3 (147 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Gria4 Glutamate receptor ionotropic, AMPA 4 (112 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 254.21Molecular Weight (Monoisotopic): 254.0764AlogP: -1.47#Rotatable Bonds: 4
Polar Surface Area: 153.18Molecular Species: ZWITTERIONHBA: 9HBD: 3
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 1.81CX Basic pKa: 8.80CX LogP: -2.52CX LogD: -4.25
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.59Np Likeness Score: -0.74

References

1. Bang-Andersen B, Lenz SM, Skjaerbaek N, Søby KK, Hansen HO, Ebert B, Bøgesø KP, Krogsgaard-Larsen P..  (1997)  Heteroaryl analogues of AMPA. Synthesis and quantitative structure-activity relationships.,  40  (18): [PMID:9288165] [10.1021/jm970253b]
2. Vogensen SB, Clausen RP, Greenwood JR, Johansen TN, Pickering DS, Nielsen B, Ebert B, Krogsgaard-Larsen P..  (2005)  Convergent synthesis and pharmacology of substituted tetrazolyl-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid analogues.,  48  (9): [PMID:15857151] [10.1021/jm050014l]
3. Sainas S, Temperini P, Farnsworth JC, Yi F, Møllerud S, Jensen AA, Nielsen B, Passoni A, Kastrup JS, Hansen KB, Boschi D, Pickering DS, Clausen RP, Lolli ML..  (2019)  Use of the 4-Hydroxytriazole Moiety as a Bioisosteric Tool in the Development of Ionotropic Glutamate Receptor Ligands.,  62  (9): [PMID:30943028] [10.1021/acs.jmedchem.8b01986]

Source